Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Quality-by-Design (QbD) in Cream Production – V 2.0

Posted on By

Creams: SOP for Quality-by-Design (QbD) in Cream Production – V 2.0

Standard Operating Procedure for Quality-by-Design (QbD) in Cream Production

Department Creams
SOP No. SOP/CRM/074/2025
Supersedes SOP/CRM/074/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to implement Quality-by-Design (QbD) principles in cream production. QbD is used to ensure that product quality is designed and built into the cream manufacturing process through systematic planning and understanding of critical process parameters (CPPs) and critical quality attributes (CQAs).

2. Scope

This SOP applies to the integration of QbD principles throughout the cream production process. It includes identification, evaluation, and control of critical parameters to ensure consistent product quality and compliance with regulatory requirements.

3. Responsibilities

  • Production Team: Responsible for applying QbD principles during production, ensuring that critical parameters are met and documented.
  • Quality Control (QC): Ensures that all critical parameters and attributes are tested, monitored, and validated throughout the production process.
  • Quality Assurance (QA): Oversees the application of QbD principles, ensures compliance with regulatory standards, and reviews process validation reports.
  • R&D Team: Assists in identifying key process variables and product characteristics to be controlled under the QbD framework.
See also  Creams: SOP for Inspection of Final Cream Batch Quality - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that QbD principles are integrated into cream production. The QA Manager is responsible for ensuring that the QbD approach meets GMP standards and regulatory guidelines.

5. Procedure

5.1 Identify Critical Quality Attributes (CQAs)

  1. Review the formulation and process flow to identify CQAs that impact the final cream product quality (e.g., texture, spreadability, consistency, stability).
  2. Ensure that CQAs are aligned with customer expectations, regulatory requirements, and product specifications.
  3. Document the identified CQAs and specify acceptable ranges for each parameter.

5.2 Identify Critical Process Parameters (CPPs)

  1. Identify the process parameters that affect the CQAs, such as mixing speed, temperature, time, and ingredient ratios.
  2. Ensure that all identified CPPs are measurable and controllable during the production process.
  3. Define the optimal operating conditions for each CPP based on formulation requirements and previous batch records.

5.3 Process Design and Risk Assessment

  1. Perform a risk assessment to determine the impact of each identified CPP on the CQAs. Use tools such as Failure Mode Effects Analysis (FMEA) or Design of Experiments (DOE) to assess the risk of variation in each parameter.
  2. Establish control strategies to minimize the risks associated with CPPs, ensuring that the process consistently produces a product that meets the required quality standards.
See also  Creams: SOP for Environmental Monitoring during Material Dispensing - V 2.0

5.4 Process Control and Monitoring

  1. Implement a process monitoring system to continuously measure and control CPPs during the production process. Ensure real-time data is recorded for every batch.
  2. Monitor each identified parameter throughout the cream production process, ensuring it remains within defined limits. If any parameters deviate from the set limits, initiate corrective actions.

5.5 Validation and Process Optimization

  1. Conduct validation studies to demonstrate that the process is capable of consistently producing products that meet quality standards within the identified CPP ranges.
  2. Optimize the process by reviewing batch records, product test results, and feedback from QC to make necessary adjustments and improvements to the production process.

5.6 Documentation

  1. Document all findings, including identified CQAs and CPPs, risk assessments, control strategies, and monitoring data.
  2. Maintain process validation records and continuous improvement data in the QbD documentation (Annexure-1).
  3. Ensure all records are reviewed by QA for compliance with regulatory guidelines and GMP standards.

5.7 Final Approval

  1. The QA team must review all QbD documentation, including risk assessments, process control records, and validation reports, before approving the cream production process for continued use or scaling up.
  2. After approval, the process is validated and approved for commercial production.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • QbD: Quality-by-Design
  • FMEA: Failure Mode Effects Analysis
  • DOE: Design of Experiments
See also  Creams: SOP for Handling Discrepancies in Dispensing Weights - V 2.0

7. Documents

  1. Annexure-1: QbD Documentation
  2. Annexure-2: Risk Assessment Report
  3. Annexure-3: Process Control Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidelines for Cosmetics Manufacturing
  • ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: QbD Documentation

Batch Number Identified CQAs Critical Process Parameters (CPPs) Risk Assessment Method Control Strategy
12345 Texture, Consistency Mixing Speed, Temperature FMEA Optimized Mixing Time

Annexure-2: Risk Assessment Report

Risk Factor Likelihood Impact Mitigation Measures
Mixing speed variation Medium High Regular monitoring, set parameters

Annexure-3: Process Control Log

Batch Number Process Parameter Recorded Value Target Value Deviation
12345 Mixing Speed 3000 RPM 3000 RPM None

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: SOP for Regular Preventive Maintenance of Storage Equipment – V 2.0
Next Post: Aerosol: SOP for Labeling Aerosol Cans Post-Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version